Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT05338931 · RECRUITING

Trial details

NCT number: NCT05338931
Sponsor: AbClon
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma

Start date: 2022-03-15
Primary completion: 2030-03-15
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.